Výsledky vyhledávání - "Bruscagnin, G"

Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial. Italian Multicentre Breast Study with Epirubicin

Autor: Ambrosini G, Palazzotto G, Becchi G, Fornasiero A, Fiorentino M, Calabresi F, Viaro D, Grignani F, Farris A, Foggi Cm, Pastorino G, Rausa L, Bonciarelli G, Fila G, Cartei G, Jirillo A, Bumma C, Di Costanzo F, Capodicasa E, Giuseppe Altavilla, Secondo, Giusto M, Adamo, Lopez M, Lacroix F, Sartori S, Speranza Gb, Palmeri S, Gallo L, Di Lauro L, Minotti, Sacchetti G, Spinelli I, Demicheli R, Maurizio Tonato, Marsilio P, Vici P, Buzzi F, Brugia M, d'Aquino S, Papaldo P, Fosser, Blasina B, Puccetti C, Gambi A, Camilluzzi E, Ardia A, Falchi Am, De Micheli P, Marenco G, Natali M, Cusimano Mp, Zingali G, Daniele O, Poggio R, Moro G, Saccani F, Garusi G, Balli M, D'Alessandro N, Schieppati G, Ciambellotti E, Gebbia N, De Maria D, Padalino D, Bonanni F, Di Carlo A, Bruscagnin G, Bertoncelli P, Chiesa G, Tagliagambe A, Intini C, Folco U

Publikováno v: Journal of Clinical Oncology. 6:976-982

From February 1983 to January 1985, 497 patients with advanced breast cancer were randomly allocated to receive either epirubicin or doxorubicin in the following combination chemotherapy regimen: fluorouracil (5-FU) 500 mg/m2 intravenous (IV) on days

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c07f35d8ecda32686c06f28befd78dbe
https://doi.org/10.1200/jco.1988.6.6.976

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání